CasLoc logo
All Cases PTAB Litigations UPC Oppositions
The patent has been granted The patent has been granted, Grant of patent is intended, Request for examination was made, The international publication has been made, unknown EP Register Verified

DRUG DELIVERY DEVICE

Publication No. EP4037735
•
App No. EP20792812
•
Filed by Amgen Inc.
•
Filed on 2020-09-29
•
Issued/Published on 2025-09-03
Publication No. EP4037735 A1
Application No. EP20792812 Filed: 2020-09-29
Grant Date 2025-09-03 Mention of grant
Active Oppositions 2 Active EPO Oppositions

Patent Abstract / Summary

Patent abstract is being processed or was not provided in English by the publishing office.

IPC Classifications

A61M5/28, A61M5/315, A61M5/20, A61M5/32

Priority Claims

US 201962908504P Date: 2019-09-30
US 202062961048P Date: 2020-01-14

Designated Contracting States (38 EPC States)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Parties & Representation

Applicants

Amgen Inc.

One Amgen Center Drive, Thousand Oaks CA 91320

US

Inventors (4)

FINKELSTEIN, Emil

C/o Amgen Inc., One Amgen Center Drive

US

EILERTSEN, Lars

C/o Amgen Inc., One Amgen Center Drive

US

SORENSEN, Michael

C/o Amgen Inc., One Amgen Center Drive

US

MADURO NORBO, Tobias

C/o Amgen Inc., One Amgen Center Drive

US

Representatives / Agents

Bijvank, Koen Mattijs Lodewiek

Brinkhof N.V., Grote Bickersstraat 74-78

NL

J A Kemp LLP

80 Turnmill Street, London EC1M 5QU

GB

Vossius & Partner Patentanwälte Rechtsanwälte mbB

Siebertstrasse 3, 81675 München

DE

Maiwald GmbH

Elisenhof, Elisenstraße 3

DE

Key Procedural Dates

Request-For-Examination 2022-03-16
First-Examination-Report-Despatched 2025-03-24